Waters Corporation key statistics and ratios
In fiscal 2025, Waters Corporation had return on equity of 29.3% and a net margin of 20.3%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | 21.6% | — | — | 25.0% | 23.6% | 21.7% | 23.0% | 24.1% | 0.9% | 24.5% | 24.6% | 22.1% | 24.9% | 23.8% | 21.7% | 21.6% | 20.3% | 3.6% |
| Return on equity | 38.1% | — | — | 34.3% | 27.9% | 23.6% | 23.7% | 23.9% | 0.9% | 31.2% | 87.7% | — | — | 162.3% | 77.6% | 42.8% | 29.3% | 1.9% |
| Return on assets | 16.9% | — | — | 15.7% | 13.3% | 11.6% | 11.5% | 11.7% | 0.4% | 13.1% | 18.8% | 19.3% | 23.3% | 22.2% | 16.2% | 13.9% | 13.3% | 1.1% |
| Effective tax rate | 16.4% | 12.8% | 15.0% | 5.4% | 8.2% | 12.0% | 13.4% | 13.1% | 96.8% | 13.0% | 12.7% | 14.6% | 14.1% | 15.5% | 12.8% | 15.5% | 14.9% | 19.1% |
| R&D as % of revenue | 5.1% | 5.1% | 5.0% | 5.2% | 5.3% | 5.4% | 5.8% | 5.8% | 5.7% | 5.9% | 5.9% | 6.0% | 6.0% | 5.9% | 5.9% | 6.2% | 6.2% | 6.9% |
| SG&A as % of revenue | 28.1% | 27.1% | 26.5% | 25.9% | 25.9% | 25.8% | 24.3% | 23.6% | 23.6% | 22.2% | 22.2% | 23.4% | 22.5% | 22.1% | 24.9% | 23.3% | 26.2% | 26.8% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Apr 2026 | 2026 Q2Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Net margin | 21.8% | 26.5% | 18.3% | 19.1% | 18.6% | 24.2% | −5.7% | −8.3% |
| R&D as % of revenue | 6.1% | 5.4% | 7.0% | 6.3% | 6.7% | 5.0% | 7.6% | 7.4% |
| SG&A as % of revenue | 22.8% | 19.9% | 26.4% | 26.1% | 26.8% | 25.7% | 30.5% | 24.6% |
Financial health
- Short-term assets cover short-term liabilities $4.5bn of assets due within a year against $2.4bn of liabilities due within a year.
- Short-term assets cover long-term liabilities $4.5bn short-term assets against $7.2bn of longer-dated liabilities.
- More cash than debt $539m of cash against $4.9bn of debt.
- Debt below 40% of shareholders' equity Debt is 32% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 412% to 32% over five years.
- A year's operating cash flow covers at least 20% of debt $550m of operating cash flow against $4.9bn of debt.
- Operating profit covers interest at least five times over Operating income of $330m against $149m of interest.
Moat
Strong moat
How hard Waters's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 20 / 20
Cash operating profit has been a median 23.2% of total assets over 10 years.
- Pricing power 20 / 20
Gross margin has been a median 59.0%, moving by 1.8 percentage points (standard deviation) across 10 years.
- Durability 13 / 20
Operating margin has been a median 28.5%; its worst year was 7.1%.
- Cash conversion 20 / 20
Free cash flow was positive in 10 of 10 years, at a median 22.6% of revenue.
- Discipline 10 / 20
The diluted share count rose 20.1% over five years; stock-based pay has been a median 1.6% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (83 before it).
Compare with peers
- Illumina, Inc. statistics
- Mettler Toledo statistics
- Charles River Laboratories statistics
- Bruker Corp statistics
- Avantor, Inc. statistics
Head to head: ILMN vs WATMTD vs WATCRL vs WATAVTR vs WAT
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies